PeptideDB

Hedgehog IN-7

CAS: F: C27H27FN8 W: 482.56

Hedgehog IN-7 (Compound 8g), a purine derivative, acts as an inhibitor of Hedgehog, capable of reducing the expression o
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Hedgehog IN-7 (Compound 8g), a purine derivative, acts as an inhibitor of Hedgehog, capable of reducing the expression of Hedgehog genes and inhibiting Hedgehog signaling. Hedgehog IN-7 has significant cytotoxicity and selectivity towards theHedgehog pathway-dependent pancreatic cancer cell Mia-PaCa-2 cells and can be used in the research of pancreatic cancer[1].
Invitro Hedgehog IN-7 (Compound 8g) 对 MIA-PaCa-2 细胞具有细胞毒性 (IC50 = 4.11 μM),对 HEK293 无细胞毒性 (IC50 ) > 50 μM)[1]。Hedgehog IN-7 (48 h) 在 NIH3T3 SHh-Light II 细胞中能抑制 Hedgehog 的信号传导,IC50 值为 6.4 μM[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Hedgehog IN-7 相关抗体:
Formula C27H27FN8
Molar Mass 482.56
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Espinosa-Bustos C, et al. New Smoothened ligands based on the purine scaffold as potential agents for treating pancreatic cancer[J]. Bioorganic Chemistry, 2024, 151: 107681.